Trial NCT04025216

View at ClinicalTrials.gov 
Org. Study IDs: CART-TnMUC1-01

Last trial update was posted on 2024-01-24

MeSH Interventions

Cyclophosphamide Fludarabine

MeSH Conditions

Fallopian Tube Neoplasms Multiple Myeloma Neoplasms, Plasma Cell Triple Negative Breast Neoplasms

Other Conditions

Fallopian Tube Cancer Non-Small Cell Lung Cancer Ovarian Cancer Pancreatic Ductal Adenocarcinoma Triple Negative Breast Cancer

Stopping Reasons

The sponsor finds the risk/benefit analysis unfavorable and has terminated the study.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID